This page shows the details of why an item matched the keywords from your search.
Property | Value |
has major subject area list
|
Bone Neoplasms; Enzyme Inhibitors; Imidazoles; Matrix Metalloproteinase Inhibitors; Neoplasms, Hormone-Dependent; Prostatic Neoplasms
|
information resource reference
|
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases. Clin Cancer Res. 2006 Mar 01; 12(5):1556-63.
|
label
|
A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
|